Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The question of whether nicotine, the neuroactive compound of tobacco, is addictive has been open to considerable scientific and public discussion. Although it can serve as a positive reinforcer in several animal species, including man, nicotine is thought to be a weak reinforcer in comparison with addictive drugs such as cocaine and heroin, and has been argued to be habit forming but not addictive. Here we report that intravenous nicotine in the rat, at doses known to maintain self-administration, stimulates local energy metabolism, as measured by 2-deoxyglucose autoradiography, and dopamine transmission, as estimated by brain microdialysis, in the shell of the nucleus accumbens. These neurochemical and metabolic effects are qualitatively similar to those of other drugs, such as cocaine, amphetamine and morphine, which have strong addictive properties. Our results provide functional and neurochemical evidence that there are specific neurobiological commonalities between nicotine and addictive drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotine elicits its psychoactive effects by activating neuromediators centrally (e.g. dopamine, serotonin, the catecholamines, etc.).”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Nicotine’s mode of action includes both psychostimulatory and sympathomimetic effects.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Specifically, dopamine-rich brain regions representing the appetitive value of potential rewards such as the ventral striatum (Carlezon & Wise, 1996; Pontieri, Tanda, Orzi, & DiChiara, 1996; Wise, 2004; Galvan, et al., 2005; Haber & Knutson, 2009; Spicer, et al., 2007) show strong signaling during adolescence which may be indicative of earlier maturation (Galvan, et al., 2006; Geier, Terwilliger,”
From Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents (2011) · cites this paper as Pontieri, Tanda, Orzi, & DiChiara, 1996
In the citing paper
“Nicotine administration leads to increased dopamine cell firing in the ventral tegmental area [15] and increased dopamine release in the nucleus accumbens [52], actions which are thought to be critical to the properties of nicotine as an addictive drug.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Handbook of Psychopharmacology
(1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,746
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes
Tiffany, S. T. (1990) · Psychological Review · doi:10.1037/0033-295x.97.2.147 · Cited by 1,554
Specificity in the projection patterns of accumbal core and shell in the rat
Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90202-y · Cited by 1,219
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Self-citation
Research works printed but not linked: 1
- Orzi, F. et al. Eur. J. Pharmac. (in the press).
Cited by
Items 701–800 of 1,000
Laikowski, M. M., Reisdorfer, F., & Moura, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180410105135 · Cited by 18
Biological Psychiatry and Psychopharmacology
Fountoulakis, K. N., Nimatoudis, I., & Stahl, S. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-18323-3_13 · Cited by 17
Further evidence for the functional role of nonsynaptic nicotinic acetylcholine receptors
Vizi, E. S., Rózsa, B. J., Mayer, A., Kiss, J., Zelles, T., & Lendvai, B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.018 · Cited by 18
“This part of the limbic system has been implicated in the reinforcing properties of drugs of abuse (Di Chiara and Imperato, 1988; Hemby et al., 1997; Corrigall et al., 1992; Pich et al., 1997; Giros et al., 1996; Pontieri et al., 1996; Di Matteo et al., 2004).”
BackgroundOrtner, R., Schindler, S., Kraigher, D., Mendelsohn, A., & Fischer, G. (2002) · Archives of Women s Mental Health · doi:10.1007/s007370200008 · Cited by 19
“This event has been proposed to underlie the rewarding effects of nicotine, which include decreased irritability, weight loss and positive effects on attention and psychomotor function (Pontieri et al., 1996).”
BackgroundThe importance of translationally evaluating steroid hormone contributions to substance use
Maher, E. E., Strzelecki, A. M., Weafer, J. J., & Gipson, C. D. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101059 · Cited by 16
“Increased activation of nAChRs alters glutamatergic and GABAergic tone within the VTA (Mansvelder et al., 2002; Mansvelder and McGehee, 2002) resulting in increased levels of extracellular DA in the NAcore (Besson et al., 2012; Pontieri et al., 1996).”
BackgroundA reduced model of DA neuronal dynamics that displays quiescence, tonic firing and bursting
Oster, A. M., & Gutkin, B. S. (2011) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2011.07.012 · Cited by 20
“Studies of the reinforcing effects of self-administered intravenous nicotine on r dents have focused on the activation of nicotinic acetylcholine receptors (nAChRs) within the mesocorticocolimbic dopaminergic system, which projects from the VTA to the nucleus accumbens (NA) and the prefontal cortex (PFC) [15, 16, 17,…”
BackgroundExamining the association between substance use disorder treatment and smoking cessation
Shu, C., & Cook, B. L. (2015) · Addiction · doi:10.1111/add.12879 · Cited by 16
Jackson, K. J., & Damaj, M. I. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.005 · Cited by 16
“, 1986), and subsequent dopamine release in the nucleus accumbens is a process thought to underlie the addictive properties of nicotine (Pontieri et al., 1996).”
Preventing Lung Cancer by Treating Tobacco Dependence
Hurt, R. D., Ebbert, J. O., Hays, J. T., & McFadden, D. D. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.004 · Cited by 16
Kim, S. E., Shim, I., Chung, J.-K., & Lee, M. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300945 · Cited by 17
“Evidence suggests that nicotine, the neuroactive compound of tobacco, has common neurochemical as well as behavioral properties with other addictive drugs such as cocaine and amphetamine (Henningfield and Heishman, 1995; Pontieri et al, 1996).”
BackgroundLi, L., Liu, Y., Zhang, Y., Beveridge, T. J. R., & Zhou, W. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.05.003 · Cited by 16
Smoking and depression among psychiatric patients
Tanskanen, H. V. A. (1999) · Nordic Journal of Psychiatry · doi:10.1080/080394899426710 · Cited by 17
Tobacco smoking as a chronic disease: notes on prevention and treatment
Batra, V., Patkar, A. A., Weibel, S., & Leone, F. T. (2002) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(02)00016-7 · Cited by 19
Sagara, H., Kitamura, Y., Yae, T., Shibata, K., Suemaru, K., Sendo, T., Araki, H., & Gomita, Y. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08168fp · Cited by 17
Vargiu, R., Broccia, F., Lobina, C., Lecca, D., Capra, A., Bassareo, P. P., & Bassareo, V. (2021) · Pharmaceuticals · doi:10.3390/ph14070609 · Cited by 18
de Guglielmo, G., Iemolo, A., Nur, A., Turner, A. V., Montilla‐Perez, P., Martinez, A. R., Crook, C., Roberts, A. J., & Telese, F. (2022) · Genes Brain & Behavior · doi:10.1111/gbb.12828 · Cited by 16
“In particular, all drugs of abuse are thought to activate the shell subregion of the NAc.(56,57) In line with the behavioral data that showed no differences in the rewarding effects of cocaine, we did not find any differences in Fos activation in the nucleus accumbens shell of HR and WT mice”
ResultCharntikov, S., Pittenger, S. T., Swalve, N. L., Li, M., & Bevins, R. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.026 · Cited by 16
Sziráki, I., Sershen, H. W., Benuck, M., Hashim, A., & Lajtha, Á. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09326.x · Cited by 15
Benowitz, N. L., & Brunetta, P. G. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00046-4 · Cited by 18
Overview of Nicotine Withdrawal and Negative Reinforcement (Preclinical)
George, O., & Koob, G. F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00001-6 · Cited by 20
Methadone’s effect on nAChRs—a link between methadone use and smoking?
Talka, R., Tuominen, R. K., & Salminen, O. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.031 · Cited by 16
Locomotor stimulant effects of nornicotine: role of dopamine
Green, T. A., Brown, R. W., Phillips, S. B., Dwoskin, L. P., & Bardo, M. T. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00960-7 · Cited by 17
Neurons of human nucleus accumbens
Sazdanovic, М., Sazdanovic, P. S., Mačužić, I. Ž., Jakovljevic, V. L., Jeremić, D., Peljto, A., & Toševski, J. (2011) · Vojnosanitetski pregled · doi:10.2298/vsp1108655s · Cited by 19
Reduced platelet vesicular monoamine transporter density in smoking schizophrenia patients
Schwartz, K., Iancu, I., Stryjer, R., Chelben, J., Kotler, M., Weizman, A., & Rehavi, M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.02.005 · Cited by 15
The Tobacco Industry in New Zealand: A Case Study of the Behaviour of Multinational CompaniesPreprint
Thomson, G., & Wilson, N. (2003) · RePEc: Research Papers in Economics · Cited by 16
McGrath, D. S., Dorbeck, A., & Barrett, S. P. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32835f3cff · Cited by 14
“neurochemical underpinnings of tobacco use (Pontieri et al., 1996) and gambling (Breiter et al.”
BackgroundComparative effects of tobacco smoking and nasal nicotine
Teter, C. J., Asfaw, B., Ni, L., Lutz, M., Domino, E. F., & Guthrie, S. K. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0481-2 · Cited by 14
“A large body of basic neuroscience data indicates tobacco addiction involves nicotine [1], which releases the neurotransmitter dopamine (DA), similar to other drugs of abuse [2].”
BackgroundQiu, T., Xie, F., Zeng, Q., Shen, Z., Du, G., Xu, X., Wang, C., Li, X., Luo, X., Li, K., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13852 · Cited by 16
Expectancies for smoking cessation among drug-involved smokers: Implications for clinical practice
Hendricks, P. S., Peters, E. N., Thorne, C. B., Delucchi, K., & Hall, S. M. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.10.011 · Cited by 14
Zhang, X., Chen, D. C., Xiu, M. H., Hui, L., Liu, H., Luο, X., Zuo, L., Zhang, H., Kosten, T. A., & Kosten, T. R. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.011 · Cited by 14
“The mechanisms linking the DBH 5′-Ins/Del and smoking severity may be related to nicotine's activation of dopaminergic neurons in themesolimbic reward pathway and enhancement of dopamine release (Pontieri et al., 1996).”
BackgroundRaffa, R. B., Baron, S., Bhandal, J. S., Brown, T., Song, K., Tallarida, C. S., & Rawls, S. M. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.09.012 · Cited by 14
“…De Vries and Schoffelmeer, 2005; Di Matteo et al., 1999; Fu et al., 2000; Hollander et al., 2008; Isola et al., 2009; Liechti and Markou, 2008; Maldonado et al., 2006; Marty et al., 1985; McGehee et al., 1995; Pontieri et al., 1996; Scherma et al., 2008; Wilkie et al., 1993; Yang et al., 1996).”
Kim, D. H., & Suh, Y. S. (2009) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2009.30.7.494 · Cited by 14
Stairs, D. J., Neugebauer, N. M., Wei, X., Boustany, C., Hojahmat, M., Cassis, L. A., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0610-1 · Cited by 16
“S(−)-nicotine engenders self-administration behavior through activation of dopamine (DA) cell bodies in the ventral tegmental area, resulting in increased levels of extracellular DA in the nucleus accumbens (Calabresi et al. 1989; Corrigall et al. 1992, 1994; Pontieri et al. 1996).”
BackgroundDopamine — Acetylcholine Interactions
Acquas, E., & Chiara, G. D. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06765-9_3 · Cited by 14
Self-citationVarenicline: progress in smoking cessation treatment
Glover, E. D., & Rath, J. M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1757 · Cited by 16
“The nicotinic acetylcholine receptor (nAChR) system in the ventral tegmental area (VTA) performs a crucial role in nicotine reinforcement [33] , mediated in particular by α 4 β 2 receptors [14,33-39] .”
BackgroundBrain imaging research on subjective responses to psychotropic drugs
Voruganti, L. P., & Awad, A. G. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00541.x · Cited by 15
“Recently, NAc has been extensively investigated as the seat of subjective responses (7).”
Acción de la nicotina como antidepresivo y regulador del sueño en sujetos deprimidos
Vieyra-Reyes, P., Venebra-Muñoz, A., Rivas-Santiago, B. T., & García, F. G. (2009) · Revista de Neurología · doi:10.33588/rn.4912.2009158 · Cited by 18
Acute Nicotine-Induced Tachyphylaxis Is Differentially Manifest in the Limbic System
Zuo, Y., Lu, H., Vaupel, D. B., Zhang, Y., Chefer, S. I., Rea, W. P., Moore, A. V., Yang, Y., & Stein, E. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.139 · Cited by 14
“…of moderate doses of nicotine on cerebral glucose metabolism were restricted to subcortical structures (London et al, 1988; McNamara et al, 1990; Pontieri et al, 1996), whereas widespread effects in cortical areas appeared only with an exceedingly high, 10 mg/kg intraperitoneal dose,…”
BackgroundPerioperative Smoking Cessation
de Hoyos, A., Southard, C., & DeCamp, M. M. (2011) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2011.09.006 · Cited by 13
Sun, H., Guo, S., Chen, D., Yang, F., Zou, Y., Di, X.-L., Cao, Y., Kosten, T. R., Lü, L., & Zhang, X. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0841-8 · Cited by 15
“Nicotine stimulates the release of dopamine from ventral tegmental neurons into the nucleus accumbens and medial frontal cortex, an action thought to underlie its rewarding effects (Pontieri et al. 1996; Rice and Cragg 2004; Zhang et al. 2004).”
BackgroundNicotine potentiates vascular endothelial growth factor expression in balloon-injured rabbit aortas
Yao, Z., Ruixing, Y., Qi, B., & Wu, J. (2008) · Growth Factors · doi:10.1080/08977190802292640 · Cited by 13
“Nicotine, a psychoactive/addictive component in cigarette smoke, exerts its biological effects by binding to the nicotinic acetylcholine receptor (nAChR; Pontieri et al. 1996; Mihailescu and Drucker-Colı́n 2000).”
BackgroundCoptidis Rhizoma attenuates repeated nicotine-induced behavioural sensitization in the rat
Lee, B., Yang, C. H., Hahm, D., Lee, H., Choe, E. S., Pyun, K.-H., & Shim, I. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.12.0008 · Cited by 13
“Nicotine activates dopamine release in the nucleus accumbens and striatum (Imperato et al 1986; Pontieri et al 1996).”
BackgroundPatten, C. A., Hurt, R. D., Offord, K. P., Croghan, I. T., Gomez‐Dahl, L. C., Kottke, T. E., Morse, R. M., & Melton, L. J. (2003) · American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00541.x · Cited by 16
HMG-CoA synthase 2 drives brain metabolic reprogramming in cocaine exposure
Shao, X., Tang, Y., Long, H., Gu, H., Zhang, J., Deng, P., Zhao, Y., & Cen, X. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.001 · Cited by 14
“Notably, psychostimulants induce tremendous changes in energy metabolism in the nucleus accumbens (NAc), a key brain region associated with drug dependence (Downey and Loftis, 2014; Li et al., 2014; Pontieri et al., 1996).”
BackgroundPardo, M., Sisk, B. C., Sberveglieri, G., & Lewis, N. S. (2005) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2005.10.033 · Cited by 13
Sorimachi, M., Yamagami, K., & Wakamori, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02473-3 · Cited by 13
Involvement of dopamine receptors in diethylpropion-induced conditioning place preference
Planeta, C. S., & DeLucia, R. (1998) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1998000400014 · Cited by 13
“property of abused drugs such as cocaine, amphetamine, nicotine, ethanol and morphine (13,14).”
BackgroundHays, J. T. (2000) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200007000-00001 · Cited by 14
Nafion‐multi‐walled Carbon Nanotubes Supported Tris(bipyridyl)iron(II) for Nicotine Detection
Tiwari, A., Yadav, M., Singh, D. K., & Ganesan, V. (2022) · Electroanalysis · doi:10.1002/elan.202200106 · Cited by 13
Alhaddad, H., Wong, W., Sari, A. T., Alexander, L. E. C., & Sari, Y. (2020) · Toxics · doi:10.3390/toxics8040095 · Cited by 12
Dwoskin, L. P., Pivavarchyk, M., Joyce, B. M., Neugebauer, N. M., Zheng, G., Zhang, Z., Bardo, M. T., & Crooks, P. A. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_4 · Cited by 13
Smoking and Major Depressive Disorder in Chinese Women
He, Q., Yang, L., Shi, S., Gao, J., Tao, M., Zhang, K., Gao, C., Yang, L., Li, K., Shi, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106287 · Cited by 14
“Both smoking and depression alter levels of dopamine [58,59], brainderived neurotrophic factor (BDNF) levels [60,61], and alter the activity of monoamine oxidase (MAO) [62,63].”
Justo, C. C., Carneiro-de-Oliveira, P. E., DeLucia, R., Aizenstein, M. L., & Planeta, C. S. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500042 · Cited by 14
“In fact, both psychostimulants and nicotine increase dopamine concentration in the nucleus accumbens (10,11).”
BackgroundHipólito, L., Sánchez-Catalán, M. J., Polache, A., & Granero, L. M. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.09.004 · Cited by 13
Nicotine Increases Spontaneous Glutamate Release in the Rostromedial Tegmental Nucleus
Castillo-Rolón, D., Ramírez-Sánchez, E., Arenas-López, G., Garduño, J., Hernández-González, O., Mihailescu, S., & Hernández‐López, S. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.604583 · Cited by 13
“Miller and Picciotto, 2016) and the accumbens nucleus (Pontieri et al., 1996; Picciotto et al., 1998; Zoli et al., 2002).”
BackgroundGomes, P. X. L., de Oliveira, G. V., de Araújo, F. Y. R., Viana, G. S. D. B., de Sousa, F. C. F., Hyphantis, T. N., Grunberg, N. E., Carvalho, A. F., & Macêdo, D. S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2799-5 · Cited by 12
Cholecystokinin (CCK) and the CCKA receptor gene polymorphism, and smoking behavior
Takimoto, T., Terayama, H., Waga, C., Okayama, T., Ikeda, K., Fukunishi, I., & Iwahashi, K. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2003.06.004 · Cited by 12
Choi, H. D., & Shin, W. G. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.127 · Cited by 12
Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia
Wang, Z. R., Zhou, D. F., Cao, L. Y., Tan, Y., Li, J., Lü, L., Wu, G. Y., Kosten, T. A., Kosten, T. R., & Zhang, X. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.08.012 · Cited by 12
Molecular Mechanisms of Nicotine-induced Bladder Cancer
Chen, R.-J., Ho, Y. S., Wu, C.-H., & Wang, Y.-J. (2011) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2011.10.001 · Cited by 12
Local transport kinetics of glucose during acute and chronic nicotine infusion in rat brains
Duelli, R., Staudt, R., Maurer, M. H., & Kuschinsky, W. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050109 · Cited by 12
“Differences in the effects of nicotine on local cerebral glucose utilization (LCGU) depending on the way of administration have been reported by Pontieri et al. (1996).”
BackgroundIndividual variability of dopamine release from nucleus accumbens induced by nicotine
Johnson, J. H., Zhao, C., James, J. R., & Rosecrans, J. A. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00226-9 · Cited by 13
“Based on its ability to release DA in ACC, nicotine has been likened to other drugs of abuse, including amphetamines [22].”
BackgroundHosseini, S. B., Sahraei, H., Mohammadi, A., Hatef, B., Meftahi, G. H., Chalabi-Yani, D., Ali-Beig, H., Sadeghi-Gharajehdaghi, S., & Ranjabaran, M. (2015) · Neurophysiology · doi:10.1007/s11062-015-9536-8 · Cited by 11
“data that these two parts may play different roles in the formation of a reward relation to nicotine [3, 8, 13].”
BackgroundCambiaghi, M., Grosso, A., Renna, A., Concina, G., & Sacchetti, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.036 · Cited by 12
“…in tobacco smoke e are mediated by the activation of nicotinic acetylcholine receptors (nAChRs), which are present in several brain regions and tied to different cellular processes (McGehee et al., 1995; Pontieri et al., 1996; Chiamulera, 2005; Laviolette and van der Kooy, 2004; Metherate, 2004).”
InfluentialSharma, R., DuMontier, S. P., deRoode, D., Sahota, P. K., & Thakkar, M. M. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12538 · Cited by 12
“…rewarding or reinforcing properties of alcohol and/or nicotine are associated with the activation of nucleus accumbens (NAc) (Koob and Volkow, 2010; Pontieri et al., 1996; Pontieri et al., 1998), we hypothesized that bilateral nicotine infusion in the BF will enhance alcohol induced activation of…”
BackgroundUeno, K., Kiguchi, N., Kobayashi, Y., Saika, F., Wakida, N., Yamamoto, C., Maeda, T., Ozaki, M., & Kishioka, S. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13172fp · Cited by 11
Akdağ, E., Kayır, H., & Uzbay, T. I. (2010) · Synapse · doi:10.1002/syn.20886 · Cited by 11
“Nicotine, which is responsible for tobacco addiction, has some behavioral and neurochemical properties similar to psychostimulant drugs such as amphetamine and cocaine (Bryne, 1988; Pointieri et al., 1996).”
BackgroundKótyuk, E., Németh, N., Rónai, Z., Demetrovics, Z., Sasvári‐Székely, M., & Székely, A. (2016) · Journal of Genetics · doi:10.1007/s12041-016-0701-7 · Cited by 11
Quintanilla, M. E., Morales, P., Ezquer, F. E., Ezquer, M., Herrera‐Marschitz, M., & Israel, Y. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.617418 · Cited by 13
Chen, G., Payne, T. J., Lou, X.-Y., Ma, J. Z., Zhu, J. Z., & Li, M. D. (2008) · Human Genetics · doi:10.1007/s00439-008-0558-9 · Cited by 11
“Nicotine exerts its pharmacological eVects on the central nervous system by binding to nicotinic acetylcholine receptors (Leonard and Bertrand 2001), and increases dopamine levels in the nucleus accumbens (Pontieri et al. 1996).”
Rodríguez, S., Huang, S., Chen, X., Gaunt, T. R., Syddall, H. E., Gilg, J. A., Miller, G. J., Cooper, C. C., Cook, D. G., Whincup, P. H., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000178314.48619.5f · Cited by 12
Negative affectivity in smokers applying to smoking cessation clinics: a case-control study
Cosci, F., Schruers, K. R. J., Pistelli, F., & Griez, E. J. L. (2008) · Depression and Anxiety · doi:10.1002/da.20473 · Cited by 11
Héritabilité et gènes candidats dans le tabagisme
Hamdani, N., Adès, J., & Gorwood, P. A. P. M. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76275-3 · Cited by 12
No Rest for the Wicked: The Epidemic Life Cycle of Wicked Consumer Behavior
Koch, M., & Orazi, D. C. (2017) · Journal of Macromarketing · doi:10.1177/0276146717715745 · Cited by 13
“Nicotine, long thought to be habit forming but not addictive, has been found to produce neurochemical and metabolic effects similar to addictive drugs such as heroin and cocaine (Pontieri et al. 1996).”
BackgroundNeurobiological Theories of Addiction
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50046-1 · Cited by 11
Khalki, H., Navailles, S., Piron, C., & Deurwaerdère, P. D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.03.047 · Cited by 13
Luty, J. S., Kelly, C., & McCreadie, R. G. (2002) · Journal of Substance Use · doi:10.1080/14659890110110374 · Cited by 11
“The reinforcing and reward properties of nicotine are mediated through its activation of the mesolimbic dopamine system (Pontieri et al. 1996).”
BackgroundHow Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science
Jensen, K. P., DeVito, E. E., & Sofuoglu, M. (2016) · Tobacco Regulatory Science · doi:10.18001/trs.2.4.14 · Cited by 12
Benowitz, N. L., & Brunetta, P. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00040-7 · Cited by 11
Carbidopa/levodopa for smoking cessation: a pilot study with negative results
Hurt, J. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011321 · Cited by 11
Lauro, I. S., Lores, L. M. V., Coll, F., Carreras, J. M., & Quesada, M. (2002) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(02)75238-1 · Cited by 14
Golden, A. K., & Davis, J. M. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s509971 · Cited by 11
“69,70 When nicotine binds to nAChRs, it triggers dopamine release from the VTA to the NAc, 67,68 enhancing reward and motivation.”
Activation of α7 nicotinic receptors suppresses sucrose addiction in mice
Kawamura, N., Novianti, E., Yamada-Goto, N., Nakama, R., Asakawa, A., Katsuura, G., & Inui, A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110439 · Cited by 10
“Previous reports indicate that nicotine activates the mesolimbic dopamine system (Pontieri et al., 1996; Pich et al., 1997).”
BackgroundStage of change of cigarette smoking in drug dependent patients
Kolly, S. (2004) · Swiss Medical Weekly · doi:10.4414/smw.2004.10431 · Cited by 10
Storage, S. S., Mandelkern, M. A., Phuong, J., Kozman, M., Neary, M. K., & Brody, A. L. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.07.010 · Cited by 10
“This theory is supported by previous studies demonstrating nicotine-induced dopamine release in the ventral striatum/nucleus accumbens using microdialysis (Di Chiara and Imperato, 1988; Damsma et al., 1989; Pontieri et al., 1996; Sziraki et al., 2001).”
ResultPharmacotherapy for tobacco cessation: Nicotine agonists, antagonists, and partial agonists
Karam‐Hage, M., & Cinciripini, P. M. (2007) · Current Oncology Reports · doi:10.1007/s11912-007-0072-6 · Cited by 10
Prasad, R., & Kumar, R. (2022) · The Indian Journal of Chest Diseases and Allied Sciences · doi:10.5005/ijcdas-56-3-161 · Cited by 10
Markou, A., Chiamulera, C., & West, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00026-6 · Cited by 10
Ohlmeier, M. D., Goseberg, E., Roy, M., Dillo, W., Kordon, A., & Prox-Vagedes, V. (2011) · The European Journal of Psychiatry · doi:10.4321/s0213-61632011000300005 · Cited by 11
Dwoskin, L. P., Joyce, B. M., Zheng, G., Neugebauer, N. M., Manda, V. K., Lockman, P. R., Papke, R. L., Bardo, M. T., & Crooks, P. A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.021 · Cited by 12
“…TX 79106, United States dDepartment of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, FL 32610, United States b i o c h e m i c a l p h a r m a c o l o g y x x x ( 2 0 0 7 ) x x x – x x x a r t i c l e i n f o Article history: Received 5 June 2007…”
BackgroundZhu, B., Li, X., Chen, H., Wang, H., Zhu, X., Hou, H., & Hu, Q. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.141 · Cited by 10
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50043-6 · Cited by 10
Adermark, L., Morud, J., Lotfi, A., Jönsson, S., Söderpalm, B., & Ericson, M. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.06.001 · Cited by 10
Shams, J., Sahraei, H., Gholami, A., Haeri-Rohani, A., Alaf-Javadi, M., Sepehri, H., Salimi, S. H., & Ghoshooni, H. (2006) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3280102d68 · Cited by 11
“(2004a,b); see also Tzschentke, 1998], an effect that may be related either to their ability to release dopamine in the ventral tegmental area (Di Chiara and Imperato, 1988; Koob, 1992; Pontieri et al., 1996; Wise, 1998; Robinson and Berridge, 2003) or to their interaction with endogenous opioid systems (Koob, 1992; P…”
BackgroundRegulation of Extracellular Dopamine: Release and Uptake
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00019-2 · Cited by 10
Recent advances in the treatment of tobacco dependence
Anthenelli, R. M. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.014 · Cited by 13
“Furthermore, in vivo microdialysis studies in rodents co-administered rimonabant and nicotine found that the CB-1 antagonist blocked dopamine release in the NAcc [29].”
BackgroundInfluentialState of the Art in Sub-Phenotyping Midbrain Dopamine Neurons
Basso, V., Döbrössy, M. D., Thompson, L. H., Kirik, D., Fuller, H. R., & Gates, M. A. (2024) · Biology · doi:10.3390/biology13090690 · Cited by 12
“Almost all the drugs of abuse, despite having different protein targets and mechanisms of action, induce the release of dopamine in the NAc from the VTA, causing a sensation of pleasure [107–109].”
BackgroundJugessur, A., Gjessing, H. K., Wilcox, A. J., Nguyen, T. T., Nilsen, R. M., Murray, J. C., & Lie, R. T. (2012) · Norsk Epidemiologi · doi:10.5324/nje.v21i2.1500 · Cited by 10
“Nicotine stimulates local energy metabolism and triggers dopamine release in the shell compartment of the nucleus accumbens— the key structure of the brain responsible for reward, motivation and dependence (29).”
BackgroundFrom Nicotine Dependence to Genetic Determinants of Smoking
Torre, G. L., Saulle, R., Nicolotti, N., de Waure, C., Gualano, M. R., & Boccia, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7046-5_1 · Cited by 9
Calakos, K. C., Hillmer, A. T., Angarita, G. A., Baldassarri, S. R., Najafzadeh, S., Emery, P. R., Matuskey, D., Huang, Y. H., & Cosgrove, K. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab208 · Cited by 9
Metadata
- Authors
- Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D.
- Affiliations
- Sapienza University of Rome (IT)
- University of Cagliari (IT)
- Istituto Neurologico Mediterraneo (IT)
- Venue
- Nature
- Published
- 1996-07
- Volume
- 382
- Issue
- 6588
- Pages
- 255-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2000363595
- Cited by
- 1,073
- References
- 33
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 14 · 2022: 14 · 2021: 22 · 2020: 23 · 2019: 14 · 2018: 21 · 2017: 24 · 2016: 31 · 2015: 23 · 2014: 34 · 2013: 44 · 2012: 44
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotine, nicotine dependence, nucleus accumbens, energy metabolism, dopamine signaling, self-administration, cocaine, amphetamine, morphine, drug addiction, positive reinforcement, 2-deoxyglucose autoradiography, cerebral microdialysis
- MeSH terms
- Animals, Deoxyglucose, Dopamine, Energy Metabolism, Injections, Intravenous, Nicotine, Nucleus Accumbens, Microdialysis, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.